Recurrent Breast Cancer Active Not Recruiting Phase 1 / 2 Trials for Ruxolitinib (DB08877)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

IndicationStatusPhase
DBCOND0028640 (Recurrent Breast Cancer)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02041429Ruxolitinib W/ Preop Chemo For Triple Negative Inflammatory BrcaTreatment